How Does Molecular Diagnostics Aid in Early Detection and Monitoring?
Molecular diagnostics can detect cancer-related changes at an early stage before clinical symptoms appear. Techniques such as liquid biopsy enable ongoing monitoring of treatment response and detection of minimal residual disease (MRD) or disease recurrence. This early and continuous monitoring can lead to timely adjustments in treatment strategies, potentially improving patient outcomes.
